Pre-operative sarcopenia is predictive of recurrent gastrointestinal bleeding on left ventricular assist device support: A multicenter analysis.


Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
06 2022
Historique:
received: 21 05 2021
revised: 13 12 2021
accepted: 03 01 2022
pubmed: 3 2 2022
medline: 26 5 2022
entrez: 2 2 2022
Statut: ppublish

Résumé

Whether pre left ventricular assist device (LVAD) sarcopenia is associated with higher incidence of gastrointestinal bleeding (GIB) on LVAD support remains unknown. To study the association between preoperative sarcopenia and post LVAD GIB events, we performed a retrospective, multi-centered study including patients with chest CTs performed ≤ 3 months prior to LVAD implantation at the University of Minnesota (n = 143) and Houston Methodist Hospital (n = 133). To quantify sarcopenia, unilateral pectoralis muscle mass indexed to body surface area (PMI) and attenuation (approximated by mean Hounsfield units; PHU The study cohort included 276 LVAD recipients with 43 % designated as bridge to transplant at the time of LVAD implantation. High pectoralis muscle mass and tissue attenuation were both protective against GIB events. Each 5 unit increase in PHU Preoperative sarcopenia, as quantified by pectoralis muscle size and attenuation, was associated with the development of recurrent GI bleeding after LVAD implantation. These CT quantitative measures appear to predict not only early mortality but morbidity on LVAD as well.

Identifiants

pubmed: 35105490
pii: S1053-2498(22)00010-9
doi: 10.1016/j.healun.2022.01.004
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

757-762

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Michael Klajda (M)

Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota.

Barry Trachtenberg (B)

Methodist DeBakey Heart and Vascular Center, Houston, Texas.

Rachel Araujo (R)

Methodist DeBakey Heart and Vascular Center, Houston, Texas.

Jerry D Estep (JD)

Department of Cardiovascular Medicine and the Heart and Vascular Institute, Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio.

Maria Masotti (M)

University of Minnesota Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota.

Levi Teigen (L)

Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, Minnesota.

Jessica Schultz (J)

Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota.

Ranjit John (R)

Department of Cardiothoracic Surgery, Division of Surgery, University of Minnesota, Minnesota.

Cindy Martin (C)

Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota.

Erik E Suarez (EE)

Methodist DeBakey Heart and Vascular Center, Houston, Texas.

Rebecca Cogswell (R)

Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota. Electronic address: cogsw14@umn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH